Newborn screening program for babies up to 4 weeks old
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests a flexible newborn screening process that looks for certain conditions early in life. It may help by catching problems sooner, when treatment can be started earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born at a ScreenPlus pilot hospital
- Your baby is less than 4 weeks old
- There is a newborn screening sample available
- Your baby is not more than 4 weeks old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers free genetic screening for rare diseases in newborns. It aims to find health conditions early so babies can get the right care sooner.
This pilot study tries a systematic way to look for several rare “lysosomal storage” diseases in newborns using a specialized lab test on routine blood samples. It may help detect these conditions earlier so treatment can start sooner if needed.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
This study offers fast genetic testing for newborns who have abnormal results on routine screens or unexplained health problems like low muscle tone, seizures, odd lab results, or bone issues. The goal is to quickly find possible genetic causes to help guide care.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
Hear when a new Acid Sphingomyelinase Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.